Cardiff Oncology
CRDF
CRDF
90 hedge funds and large institutions have $29.1M invested in Cardiff Oncology in 2024 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 33 increasing their positions, 12 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
10.02% more ownership
Funds ownership: 19.25% → 29.26% (+10%)
37% less capital invested
Capital invested by funds: $45.8M → $29.1M (-$16.8M)
Holders
90
Holding in Top 10
–
Calls
$1.86M
Puts
$238K
Top Buyers
| 1 | +$4.33M | |
| 2 | +$2.14M | |
| 3 | +$1.48M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.06M |
| 5 |
Morgan Stanley
New York
|
+$963K |
Top Sellers
| 1 | -$4.96M | |
| 2 | -$985K | |
| 3 | -$865K | |
| 4 |
HF
HRT Financial
New York
|
-$362K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$301K |